Last edition
News about "Type 2 Diabetes Mellitus"
Dr Reddy's Receives ANVISA Approval for Generic Semaglutide in Brazil
Dr Reddy’s Laboratories receives ANVISA marketing authorisation for its generic semaglutide injection for adults with inadequately controlled type 2 diabetes in Brazil.
Type 2 Diabetes Mellitus | 05/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members